EmVenio Insights

Author: Tomas Herrera At EmVenio Research, we strongly believe that a successful company is not just about profits and growth, but also about building meaningful connections with the communities it serves. And the month of May was no exception! We…

Esteemed pharmaceutical leader Dr. Neil Kurtz appointed to board chair DURHAM, N.C., June 1, 2023 – Clinical trial organization EmVenio Research today announced the inception of an advisory board of veteran industry leaders. The board will provide strategic oversight and…

Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent of the US…

DURHAM, N.C., May 18, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical trial access to…

Durham, NC – May 17, 2023 –       EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics and data…

EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in…

EmVenio Research’s dedication to the community is demonstrated by action. Our passion for engaging local communities is what sets us apart. On March 6th, our mobile Community Research Site was on campus! The students from Georgia Tech School of Industrial…

DURHAM, N.C., April 11, 2023 /PRNewswire/ — EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and therapeutic areas. He will also provide medical…

EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — ClearDATA®, the first and most comprehensive provider of healthcare-specific managed cloud, compliance and…

EmVenio president Thad Wolfram spoke to CenterWatch about our innovative approach to expand access and diversity in clinical trials through our fleet of mobile community research sites. Thad discussed how EmVenio was formed and its mission behind the work we…

DURHAM, N.C., March 6, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical trial access to diverse and underserved communities. EmVenio will…

EmVenio Research is committed to helping you achieve your DEI objectives and meet enrollment goals. With our 10 active Community Research Sites located in geographies providing access to underserved and difficult to reach populations, we enable you to enroll the…